MUTATIONAL HOTSPOT IN THE P53 GENE IN HUMAN HEPATOCELLULAR CARCINOMAS

被引:1421
|
作者
HSU, IC
METCALF, RA
SUN, T
WELSH, JA
WANG, NJ
HARRIS, CC
机构
[1] NCI,DIV CANC ETIOL,HUMAN CARCINOGENESIS LAB,BETHESDA,MD 20892
[2] UNIV MARYLAND,SCH MED,DEPT PATHOL,BALTIMORE,MD 21201
[3] CHINESE ACAD MED SCI,INST CANC,BEIJING,PEOPLES R CHINA
[4] QIDONG LIVER CANC INST,JIANGSU,PEOPLES R CHINA
关键词
D O I
10.1038/350427a0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
HUMAN hepatocellular carcinomas (HCC) from patients in Qidong, an area of high incidence in China, in which both hepatitis B virus and aflatoxin B1 are risk factors 1, were analysed for mutations in p53, a putative tumour-suppressor gene. Eight of the 16 HCC had a point mutation at the third base position of codon 249. The G --> T transversion in seven HCC DNA samples and the G --> C transversion in the other HCC are consistent with mutations caused by aflatoxin B1 in mutagenesis experiments 2,3. No mutations were found in exons 5, 6, 8 or the remainder of exon 7. These results contrast with p53 mutations previously reported in carcinomas and sarcomas of human lung, colon, oesophagus and breast; these are primarily scattered over four of the five evolutionarily conserved domains, which include codon 249 (refs 4-9). We suggest that the mutant p53 protein may be responsible for a selective clonal expansion of hepatocytes during carcinogenesis.
引用
收藏
页码:427 / 428
页数:2
相关论文
共 50 条
  • [31] P53 MUTATION IN HUMAN NASOPHARYNGEAL CARCINOMAS
    LO, KW
    MOK, CH
    HUANG, DP
    LIU, YX
    CHOI, PHK
    LEE, JCK
    TSAO, SW
    ANTICANCER RESEARCH, 1992, 12 (6B) : 1957 - 1964
  • [32] P53 mutations in human thyroid carcinomas
    Stenger, A
    Knabbe, C
    Jung, R
    Henke, RP
    Frilling, A
    Broelsch, CE
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1996, : 243 - 246
  • [33] P53 - A FREQUENT TARGET FOR GENETIC ABNORMALITIES IN HUMAN HEPATOCELLULAR CARCINOMAS (HCCS) IN BRITAIN
    CHALLEN, C
    WARREN, W
    GUO, K
    LUNEC, J
    BASSENDINE, MF
    HEPATOLOGY, 1991, 14 (04) : A94 - A94
  • [34] SPLICING MUTATIONS OF THE P53 GENE IN HUMAN HEPATOCELLULAR-CARCINOMA
    LAI, MY
    CHANG, HC
    LI, HP
    KU, CK
    CHEN, PJ
    SHEU, JC
    HUANG, GT
    LEE, PH
    CHEN, DS
    CANCER RESEARCH, 1993, 53 (07) : 1653 - 1656
  • [35] ABERRATION OF THE P53 GENE IN HUMAN HEPATOCELLULAR-CARCINOMA IN JAPAN
    NISHIDA, N
    FUKUDA, Y
    KOMEDA, T
    SANDO, T
    KITA, R
    FURUKAWA, M
    NAKAO, AK
    HEPATOLOGY, 1994, 19 (04) : I109 - I109
  • [36] P53 IS NOT MUTATED IN HEPATOCELLULAR CARCINOMAS FROM ALASKA NATIVES
    DEBENEDETTI, VMG
    WELSH, JA
    TRIVERS, GE
    HARPSTER, A
    PARKINSON, AJ
    LANIER, AP
    MCMAHON, BJ
    BENNETT, WP
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1995, 4 (01) : 79 - 82
  • [37] P53 MUTATIONS IN HEPATOCELLULAR CARCINOMAS (HCCS) FROM KOREA
    PARK, YM
    YOON, SK
    KIM, BS
    TABOR, E
    HEPATOLOGY, 1994, 20 (04) : A384 - A384
  • [38] OVEREXPRESSION OF P53 IN HEPATOCELLULAR CARCINOMAS - A CLINICOPATHOLOGICAL AND PROGNOSTIC CORRELATION
    NG, IOL
    LAI, ECS
    CHAN, ASY
    SO, MKP
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1995, 10 (03) : 250 - 255
  • [39] p53 and gene therapy for hepatocellular carcinoma
    Habib, NA
    Mitry, RR
    Sadri, R
    GENE THERAPY OF CANCER, 1998, 451 : 499 - 504
  • [40] Hepatocellular carcinoma and p53 gene therapy
    Fricker, J
    MOLECULAR MEDICINE TODAY, 1996, 2 (09): : 361 - 361